Lippincott ^® NursingCenter ^®

Departments

• Free

  3 Questions on... The Value of Using Clinical Pathways in Oncology

  Sarah DiGiulio

• Free

  ASCO Issues Recommendations to Improve Oncology Clinical Pathways

  Sarah DiGiulio

• Free

  Aspirin Found to Prevent Death from Prostate Cancer, but Not to Protect from Prostate Cancer

  Robert H. Carlson

• Free

  Cabozantinib Improves PFS Across Subgroups in METEOR Trial

  Robert H. Carlson

• Free

  CML Patients Who Achieve Long-term Deep Molecular Response Can Stop Imatinib

  Mark L. Fuerst

• Free

  FDA Approves Bendeka (Bendamustine Hydrochloride) Injection for CLL and NHL
• Free

  FDA Approves Tafinlar+Mekinist Combo for Melanoma
• Free

  FDA's Orphan Drug Designation to ARQ 087 for Cholangiocarcinoma
• Free

  High CTC Phenotypic Heterogeneity Predicts Shorter Survival Times in mCRPC

  Robert H. Carlson

• Free

  Musings of a Cancer Doctor: The Meticulous Frances Kelsey

  George W. Sledge MD

• Free

  Protein Associated with Myeloma & DLBCL also Found to Play Role in CTCL

  Sarah DiGiulio

• Free

  Remembering Cancer Advocate Ellen Stovall

  Peggy Eastman

• Free

  Shop Talk
• Free

  Simone's OncOpinion: Childhood Death and Grieving Survivors

  Joseph V. Simone MD

• Free

  VOICES: Clinical Benefit of Checkpoint Inhibitor Drugs Matures

  Louis M. Weiner MD

• Buy

  Best GI Oncology Research 2015

  Andrea Wang-Gillam MD, PhD

• Buy

  In CML: Radotinib as Frontline Therapy; Ponatinib Promising for T315I Patients

  Mark L. Fuerst

• Buy

  Need for Ongoing Care, Counseling, and SCPs Highlighted at Inaugural Cancer Survivorship Symposium

  Robert H. Carlson

• Buy

  Pembrolizumab Offers Treatment Help in Nasal Cancer

  Ed Susman

• Buy

  POINT-COUNTERPOINT: Sequential Therapy for mCRC

  Mark L. Fuerst